• Needham PROSE Clinic
  • Find a PROSE Clinic
  • Donate
  • Contact Us
  • Patient Care
    • PROSE Treatment
    • Find a PROSE Clinic
    • Conditions We Treat
    • Patient Stories
    • Patient Resources
    • Pediatrics
  • Technology
    • Our Products
    • Software Platforms
    • Manufacturing
  • Education
    • Visiting Clinicians
    • FitAcademy International
    • FitAcademy for Residents
    • FitAcademy Immersive
    • Ophthalmology Resident Lectures
  • Research
    • Clinical Trials and R&D Services
    • Research Studies
    • Publications
  • About
    • Our Approach
    • News
    • Our People
    • Our Partners
  • Needham PROSE Clinic
  • Find a PROSE Clinic
  • Donate
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

Wavefront Technologies Utilized for More Accurate Vision Correction

February 23, 2022/0 Comments/in Blog Posts/by michele
This post is part of BostonSight’s archival content and was originally authored by Janice M. Epstein. Content has been updated to be current.  This content is informational in nature and should not be considered medical advice. Please reach out to your medical professional for questions about your vision.  Wavefront optic technology was developed by astronomers to obtain clearer, less distorted views of planets and stars. Eye care professionals are now successfully adopting this technology to address their patients’ complex vision disorders. This new approach could dramatically change the way in which eye care providers diagnose and treat many vision issues.
iTrace aberrometer

iTrace aberrometer

Dr. Larry N. Thibos of the School of Optometry at Indiana University pioneered the use of wavefront technology in optometry. Wavefront technology uses light waves passed through the eye to obtain a detailed measurement that can more precisely describe vision disorders compared with traditional measurement techniques. By analyzing the way in which the eye refracts light, vision errors can be more accurately identified as subtle errors are revealed. This technology allows for improved diagnosis and treatment of both lower-order (most common) as well as higher-order (more complex) vision errors.

Detecting errors

In a matter of seconds, an instrument called an aberrometer uses wavefront technology to provide a detailed analysis of the eye that an eye doctor can then use to identify and correct vision errors. Technologies such as this continue to improve doctors’ ability to diagnose and treat eye diseases. For those with lower-order vision errors, such as nearsightedness or farsightedness, these precise measurements can yield more accurate vision correction with contact lenses or eyeglasses. Patients with more complex, or higher-order aberrations (HOAs), may have more subtle vision errors that are not detected with traditional methods. These issues can more easily and accurately be identified and corrected using wavefront techniques.  According to Dr. Thibos, these advanced techniques can allow for monitoring changes in optical quality for dry eye patients, for example, assessing outcomes of advanced vision-correcting therapies, and tracking visual abnormalities in growing eyes.

Wavefront Technology and HOA Correction at BostonSight

BostonSight has innovative technologies to correct HOAs.  In our BostonSight SCLERAL lenses, SmartSight® FSE (front surface eccentricity) is built-in to the lens to control HOAs.  For more challenging HOAs, practitioners with an aberrometer can harness our SmartSight HOA® technology, using virtually any aberrometer on the market.  This technology can correct significant glare, ghosting, halos, starbursts, and double vision, and can be particularly helpful for patients with post-LASIK vision issues or patients who require exceptional visual acuity, such as athletes or military personnel.  PROSE patients may also benefit from our HOA technology.
https://www.bostonsight.org/wp-content/uploads/2026/06/iTrace.jpg 226 193 michele /wp-content/uploads/2026/05/bostonsight-logo.svg michele2022-02-23 17:37:142026-06-18 11:11:04Wavefront Technologies Utilized for More Accurate Vision Correction

BostonSight Research Advances Education and Innovation in Ocular Surface Disease Treatement

February 15, 2022/0 Comments/in Press Release/by michele

Needham, Mass. –February 15, 2022 –BostonSight®, a nonprofit healthcare organization that advances the treatment of diseased or damaged corneas and dry eye continues to expand its clinical research as part of its mission to educate patients and doctors about the care and treatment of the ocular surface.

“Research and publishing are core components of our mission,” said Dr. Daniel Brocks, MD, BostonSight’s Chief Medical Officer. “We envision a world where no one suffers loss of sight from corneal irregularities or ocular surface disease. To work toward that vision, we conduct research and share our findings with other providers with the hope that our work will benefit the eye care industry as a whole.”

BostonSight conducts clinical research trials to find improved solutions for patients suffering from ocular surface disease. The research team is currently conducting four studies, including one that evaluates an at-home lens coating system for patients who use scleral lenses. Lens coating can provide a better lens wearing experience by minimizing deposits and fogging and increasing lubricity, enhancing patient comfort. For a full list of research studies go to https://www.bostonsight.org/our-research/.

In 2021, an analysis in Contact Lens and Anterior Eye listed BostonSight as the leading institution providing scleral contact lens-related articles. Recently, the research team published a peer-reviewed article about the efficacy of scleral lenses for patients with ocular GvHD. A full list of BostonSight’s peer-reviewed publications can be found at https://www.bostonsight.org/our-research/our-publications/.

In addition, research advances scleral lens technology developed by BostonSight for PROSE® treatment and BostonSight SCLERAL®.

About BostonSight®
BostonSight is a nonprofit healthcare organization that advances the treatment of diseased or damaged corneas and dry eye. Our ongoing commitment to research and achieving optimal patient outcomes through innovative scleral lens design, education, and technology has saved the sight of thousands of people around the world. BostonSight PROSE® treatment is available at top medical centers around the U.S., Canada, and India. BostonSight SCLERAL® was launched to expand access to global scleral lens technology. BostonSight SCLERAL has partnerships with Spectrum International in Latin America and L.V. Prasad Eye Institute in the Middle East and India.

Contact:

Michele Hart
BostonSight
(617) 669-4225
mhart@bostonsight.org

/wp-content/uploads/2026/05/bostonsight-logo.svg 0 0 michele /wp-content/uploads/2026/05/bostonsight-logo.svg michele2022-02-15 11:00:412022-02-15 11:00:41BostonSight Research Advances Education and Innovation in Ocular Surface Disease Treatement

Pages

  • About
  • Clinical Trials and R&D Services
  • Conditions We Treat
  • Contact Us
  • Dry Eye
  • Education
  • Find a PROSE Clinic
  • FitAcademy
  • FitAcademy for Residents
  • FitAcademy Immersive
  • FitAcademy International
  • GVHD
  • Home
  • Keratoconus
  • Manufacturing
  • Needham PROSE Clinic
  • News
  • Notice of Privacy Practices for Patients
  • Ophthalmology Resident Lectures
  • Our Approach
  • Our Partners
  • Our People
  • Our Products
  • Patient Care
  • Patient Information Booklet
  • Patient Resources
  • Patient Stories
  • Pediatrics
  • Post-Corneal Transplant
  • Post-LASIK
  • Practitioner IFU
  • Privacy Policy
  • PROSE Provider Payment Form
  • PROSE Treatment
  • Publications
  • Research
  • Research Studies
  • Sjögren’s Disease
  • Software Platforms
  • Stevens-Johnson Syndrome
  • Technology
  • Terms of Use
  • Visiting Clinicians
  • Ways to Support Us

Categories

  • Blog Posts
  • Clinic Updates
  • In the Media
  • Patient Stories
  • Press Release
  • PROSE
  • SCLERAL

Archive

  • May 2026
  • April 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • July 2025
  • June 2025
  • May 2025
  • January 2025
  • November 2024
  • October 2024
  • September 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • July 2023
  • May 2023
  • March 2023
  • February 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • July 2020
  • June 2020
  • March 2020
  • Patient Care
    • PROSE Treatment
    • Find a PROSE Clinic
    • Conditions We Treat
    • Patient Stories
    • Patient Resources
    • Pediatrics
  • Technology
    • Our Products
    • Software Platforms
    • Manufacturing Lab
  • Education
    • Visiting Clinicians
    • FitAcademy International
    • FitAcademy for Residents
    • FitAcademy Immersive
    • Ophthalmology Resident Lectures
  • Research
    • Clinical Trials and R&D Services
    • Research Studies
    • Publications
  • About
    • Our Approach
    • News
    • Our People
    • Partners
  • Needham PROSE Clinic
  • Donate
  • Contact Us

© 2026 BostonSight. All rights reserved.

Privacy PolicyTerms of Use

Scroll to top Scroll to top Scroll to top
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings ACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non Necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

Save & Accept